Patient and disease characteristics (N = 65)
| Patient and disease characteristics . | n (%) . |
|---|---|
| Age (y) | |
| Median (range) | 60 (22-87) |
| Gender | |
| Female | 33 (50.8) |
| Race | |
| White | 55 (84.6) |
| Black | 3 (4.6) |
| Asian | 3 (4.6) |
| American Indian or Alaska native | 1 (1.5) |
| Not reported/unknown | 3 (4.6) |
| Ethnicity | |
| Not Hispanic or Latino | 50 (76.9) |
| Hispanic or Latino | 10 (15.4) |
| Unspecified | 5 (7.7) |
| ECOG performance status (n = 64) | |
| 0 | 16 (25) |
| 1 | 38 (59.4) |
| 2 | 10 (15.6) |
| Presenting WBC (×103/µL) | |
| Median (range) | 23 (0.3-434) |
| BCR-ABL1 transcript (n = 50) | |
| p190 | 38 (76) |
| p210 | 12 (24) |
| Additional karyotypic abnormalities (n = 35) | |
| None | 10 (28.6) |
| 1 | 9 (25.7) |
| 2-5 | 8 (22.9) |
| >5 | 8 (22.9) |
| Monosomy 7 ±others | 7 (20) |
| Therapy for prior malignancy | |
| None/not reported | 56 (86.2) |
| Chemotherapy | 2 (3.1) |
| Radiation therapy | 5 (7.7) |
| Chemotherapy and radiation therapy | 1 (1.5) |
| Unknown treatment | 1 (1.5) |
| Patient and disease characteristics . | n (%) . |
|---|---|
| Age (y) | |
| Median (range) | 60 (22-87) |
| Gender | |
| Female | 33 (50.8) |
| Race | |
| White | 55 (84.6) |
| Black | 3 (4.6) |
| Asian | 3 (4.6) |
| American Indian or Alaska native | 1 (1.5) |
| Not reported/unknown | 3 (4.6) |
| Ethnicity | |
| Not Hispanic or Latino | 50 (76.9) |
| Hispanic or Latino | 10 (15.4) |
| Unspecified | 5 (7.7) |
| ECOG performance status (n = 64) | |
| 0 | 16 (25) |
| 1 | 38 (59.4) |
| 2 | 10 (15.6) |
| Presenting WBC (×103/µL) | |
| Median (range) | 23 (0.3-434) |
| BCR-ABL1 transcript (n = 50) | |
| p190 | 38 (76) |
| p210 | 12 (24) |
| Additional karyotypic abnormalities (n = 35) | |
| None | 10 (28.6) |
| 1 | 9 (25.7) |
| 2-5 | 8 (22.9) |
| >5 | 8 (22.9) |
| Monosomy 7 ±others | 7 (20) |
| Therapy for prior malignancy | |
| None/not reported | 56 (86.2) |
| Chemotherapy | 2 (3.1) |
| Radiation therapy | 5 (7.7) |
| Chemotherapy and radiation therapy | 1 (1.5) |
| Unknown treatment | 1 (1.5) |
Data are presented as n (%) of patients, unless otherwise indicated.
ECOG, Eastern Cooperative Oncology Group; WBC, white blood cells.